Chairman Bai Xianhong (third from left) shakes hands and poses for a photo with Cuban Ambassador to China Carlos Miguel Pérez Hernández (second from right) at the event.

On November 10, 2020, coinciding with the 60th anniversary of diplomatic relations between China and Cuba and the opening of the third China International Import Expo, Mr. Bai Xianhong, Chairman and General Manager of BIOTECH PHARMACEUTICAL CO., LTD, accepted invitations from the Cuban Embassy in China and the Cuban Consulate General in Shanghai to attend the "Cuba-China" Trade Forum held in Shanghai.

Chairman Bai Xianhong delivered a speech at the meeting, highlighting the fruitful achievements and valuable experience accumulated over the past 20 years since the establishment of the China-Cuba joint venture, Biotech Pharma. As a flagship collaboration project between China and Cuba in the biotechnology sector, Biotech Pharma has been dedicated to delivering high-quality, highly effective antibody-based therapies to patients. Notably, its newly developed and marketed drug, nivolumab, has already benefited countless cancer patients, significantly improving their survival outcomes—and with promising prospects for broader clinical applications ahead.